In search of transcription factors that may have caused the altered expression profile in T2DM patients, we identified highly enriched transcription factor binding sites for HIF1 and ARNT in genes with an aberrant expression compared to MetS patients (and lean controls). The gene discussed is HIF1A; the disease is type 2 diabetes mellitus.